Pricing Log in Create free account
Sunday 8 November 2026 Export OGN’s income statement to Excel — free account

Organon & Co.

OGN

Healthcare Drug Manufacturers General

Organon & Co.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, down 2.92% from fiscal 2024.

Revenue
−1.75%
EPS
+1.64%
Free cash flow
+118.8%
Total debt
−3.10%

Quarter to September 2026, against a year earlier

13.87 0.08 +0.58%
Market cap
$3.6B
P/E
17.3×
Fwd P/E
6.2×
Dividend yield
0.58%
F-score
5/9
ROIC
6.26%
Net debt / EBITDA
5.6×
Dividend safety
45/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Organon & Co. (OGN) P/S ratio

Alert me on P/S ratio

As of 6 November 2026, Organon & Co. (OGN) trades at a P/S ratio of 0.6×. Over the past ten years it has ranged from 0.2× (March 2026) to 1.6× (March 2022); the current reading is higher than 33% of that period. That is below the Drug Manufacturers General industry median of 3.5× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 0.3× (50.03%)
FY2024 0.6× (0.08%)
FY2023 0.6× (48.10%)
FY2022 1.2× (5.67%)
FY2021 1.2× (9.08%)
FY2020 1.3× 0.00%
FY2019 1.3× 0.00%
FY2018 1.3× 0.00%
FY2017 1.3× —

Quarterly newest first

Period P/S ratio Change
Sep 2026 0.6× 1.65%
Jun 2026 0.6× 129.28%
Mar 2026 0.3× (15.44%)
Dec 2025 0.3× (32.07%)
23 more quarters

Against its own ten years

Low 0.2× High 1.6×
Ten-year median 0.8×
Current reading's percentile 33

P/S ratio against peers

Company P/S ratio
OGN Organon & Co. 0.6×
GRFS Grifols, S.A. compare 0.7×
AMRN Amarin Corporation PLC compare 1.4×
SNY Sanofi compare 1.9×
GSK GSK PLC Sponsored ADR compare 2.2×
BMY Bristol Myers Squibb Company compare 2.5×
PFE Pfizer Inc. compare 2.6×
NVO Novo Nordisk A/S compare 3.4×
BIIB Biogen Inc. compare 3.6×
Drug Manufacturers General industry median 3.5×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on OGN